Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.
Researchers at MD Anderson used DNA and RNA sequencing to identify gene mutations linked with aggressive peritoneal metastases in gastric cancer.
